TRV Stock UPDATES The Travelers Companies Inc (TRV) 90.48 08/08/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
The Travelers Companies Inc (TRV) 90.48 $TRV

Scanning Property and Casualty Insurance Equities -- FNF Group, Assured Guaranty, XL Group, Travelers Cos, and Axis Capital
PR Newswire - Thu Aug 07, 8:20AM CDT
On Wednesday, August 6, 2014, the NASDAQ Composite ended at 4,355.05, up 0.05%, the Dow Jones Industrial Average advanced 0.08%, to finish the day at 16,443.34, and the S&P 500 closed the day flat at 1,920.24. The losses were broad based as six out of ten sectors ended the session in negative. The S&P 500 Financials Sector Index ended the day at 299.70, up 0.37%, with the index also advancing 3.01% in the previous three months. Investor-Edge has initiated coverage on the following equities: FNF Group (NYSE: FNF), Assured Guaranty Ltd (NYSE: AGO), XL Group PLC (NYSE: XL), The Travelers Companies Inc. (NYSE: TRV), and Axis Capital Holdings Ltd (NYSE: AXS). Free research on these five companies can be accessed at:

ProAssurance Q2 Earnings in Line, Down Y/Y on High Expenses - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Aug 06, 10:50AM CDT
ProAssurance Corporation (PRA) reported second-quarter 2014 operating earnings per share of 69 cents, which was in line with the Zacks Consensus Estimate.

AXIS Capital Q2 Earnings Beat on Strong Segment Performance - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jul 30, 2:50PM CDT
AXIS Capital (AXS) second-quarter 2014 earnings per share of $1.63 outperformed the Zacks Consensus Estimate by nearly 33% and improved nearly fourfold year over year.

RenaissanceRe (RNR) Q2 Earnings Miss Estimates, Improve Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jul 30, 1:17PM CDT
RenaissanceRe Holdings Ltd. (RNR) reported second-quarter 2014 operating earnings per share of $2.28 that missed the Zacks Consensus Estimate by 23.5%.

Montpelier Misses Q2 Earnings on Weak Underwriting Results - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jul 29, 11:40AM CDT
Montpelier Re (MRH) reported operating earnings of 76 cents per share in the second quarter, missing the Zacks Consensus Estimate by 22% and year ago earnings by 18%.

XL Group Beats Q2 Earnings on Solid Underwriting Results - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jul 29, 10:20AM CDT
XL Group (XL) reported second-quarter 2014 operating net income of $1.02 per share surpassed the Zacks Consensus Estimate by 22.9% and improved 36% year over year.

Downgrade Alert for Travelers (TRV)
Comtex SmarTrend(R) - Tue Jul 29, 7:17AM CDT
Travelers (NYSE:TRV) was downgraded from Buy to Hold at Sandler O'Neill today. The stock closed yesterday at $91.88 on volume of 2.5 million shares, above average daily volume of 2.0 million. The Travelers Companies, Inc. provides commercial property casualty insurance and asset management services to businesses, government units, associations and individuals. The Company underwrites homeowners and auto insurance through independent agents.

Dow Today: Travelers Companies (TRV) Lower
at The Street - Mon Jul 28, 1:00PM CDT
Holding back the Dow today is Travelers Companies (NYSE: TRV ), which is lagging the broader Dow index with a 52-cent decline (-0.6%) bringing the stock to $91.58.

Will Travelers (TRV) Stock Be Affected By This Analyst Downgrade?
at The Street - Mon Jul 28, 8:10AM CDT
Travelers (TRV) shares are down in pre-market after the company was downgraded by Sandler O'Neill today.

Dow 30 Stock Roundup: Boeing, Verizon, UTX Beat Estimates, AT&T, MSFT, MCD Miss - Analyst Blog
Swarup Gupta - Zacks Investment Research - Fri Jul 25, 1:36PM CDT
The Dow had a dismal week, weighed down by disparate factors.

Chubb Q2 Earnings Miss on Elevated Claims, Guidance Trimmed - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jul 25, 12:50PM CDT
Chubb (CB) lowers 2014 earnings guidance after suffering from elevated claims during the second quarter.

First American Financial Q2 Earnings Miss Estimates, Up Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jul 25, 8:50AM CDT
First American Financial reported second quarter 2014 operating income of 43 cents per share missing the Zacks Consensus Estimate by 12.2%.

Allied World Q2 Earnings Miss on Lower Underwriting Income - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jul 24, 1:05PM CDT
Allied World (AWH) reported second-quarter 2014 operating income of 76 cents per share, which missed the Zacks Consensus Estimate by 13.6%.

Aspen Insurance Beats Q2 Earnings on Favorable Investments - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jul 24, 12:40PM CDT
Aspen Insurance Holdings Ltd. (AHL) reported second-quarter 2014 operating net income of $1.40 per share, which beat the Zacks Consensus Estimate of $1.34 per share.

ACE Ltd Keeps Earnings Streak Alive on Q2 Solid Underwriting - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jul 23, 10:50AM CDT
ACE Limited's (ACE) operating earnings of $2.42 per share outperformed the Zacks Consensus Estimate by 8% and improved 5.7% year over year on solid underwriting and investment results.

Company News for July 23, 2014 - Corporate Summary
Zacks Equity Research - Zacks Investment Research - Wed Jul 23, 9:10AM CDT
Companies in the News are: DPZ,GCI,LXK,TRV

Second Circuit Reinstates Asbestos Judgment Against Travelers
PR Newswire - Tue Jul 22, 9:15PM CDT
Today the U.S. Court of Appeals for the Second Circuit put to rest the "private hopes and dreams" of insurer Travelers Cos. Inc., in its attempt to avoid its obligation to thousands of asbestos victims.

Travelers EPS falls on claims
at Investor's Business Daily - Tue Jul 22, 5:26PM CDT
The insurance giant's Q2 EPS fell 9.4% to $1.93, missing views by 14 cents. Catastrophe losses rose 28% to $436 mil amid severe storms and tornados that hit the central U.S. in June. A federal appeals court also ruled Tue. that Travelers (TRV) should...

Why Travelers Companies Inc Got Smacked
Jordan Wathen, The Motley Fool - Motley Fool - Tue Jul 22, 4:20PM CDT
Such is life for a stockpicker. Travelers Companies Inc reported results, and investors weren't pleased, sending the stock down nearly 4% following the announcement. Is this an overreaction from Wall Street, or a sign that things aren't going...

Stocks Protect Day's Gains; IPOs Show Some Life
at Investor's Business Daily - Tue Jul 22, 4:13PM CDT
Stocks protected most of their gains Tuesday afternoon as the market headed toward its final hour of trade. The S&P 500 was up 0.5% after notching a new intraday high in the morning. The Nasdaq gained 0.7%, and the Dow Jones industrial average added...




Scroll down for more posts ▼

Top 10 Most Recent News Articles

LG's ASIL D Certification: A Game Changer in Autos

Updated Category News Views 170

Why LG's ASIL D Certification Matters There ain't much in the tangled mess of automotive innovations these days that'll make a seasoned investor raise an eyebrow, but here comes LG Electronics grabbing the ASIL D certification like it's a badge of market honor. The ISO 26262 ASIL D is no walk in the park, folks—it's the top rung on the safety ladder, something that's...

Continue Reading
Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 245

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 108

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 358

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 336

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 364

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
Fibocom LTE Modules Test Drive Satellite Connectivity

Updated Category News Views 153

Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...

Continue Reading
Antengene’s AnTenGager-D2 Advances in Cancer Treatment

Updated Category News Views 86

Antengene's AnTenGager-D2 Offers Fresh Hope Alright, let's dig into the latest buzz from the 2026 Society for Immunotherapy of Cancer conference about Antengene's AnTenGager-D2 platform. If you're not into biotech lingo, buckle up, because this is a ride into the future of cancer treatments—where science fiction might soon become science fact. A Novel Approach to Tumor...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 372

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
Cultural Tech Fusion: The Asia-Pacific Way Forward

Updated Category News Views 64

A High-Tech Twist on Traditional Culture You ever walk into a room and see a robot perform kung fu? I'll admit, it caught me off guard at first. But that's exactly what happened at the "Enduring Heritage, Harmonious Asia-Pacific" special exhibition in Shenzhen. With all the usual high-ranking execs and cultural bigwigs there, nobody expected a showcase where Wing Chun...

Continue Reading

Top 5 Most Recently Viewed Articles

Analyzing Trump's Executive Orders and Their Economic Impact

Updated Category News Views 806

Executive Orders: A Shift in Economic Paradigms President Trump has taken significant steps by issuing a number of executive orders that have raised eyebrows among economists and market analysts alike. According to market expert Louis Navellier, this approach can be characterized as 'shock and awe'. It reflects a bold strategy that could reshape various aspects of the...

Continue Reading
B2PRIME Expands Institutional Reach with Stuart Brock's Addition

Updated Category News Views 173

B2PRIME Welcomes Stuart Brock as Institutional Business Development Manager B2PRIME Group, a leading financial services provider for institutional and professional clients, recently announced the appointment of Stuart Brock as its Institutional Business Development Manager. With over 15 years of experience in electronic trading and institutional sales, Stuart is poised to...

Continue Reading
United Parks & Resorts Inc. Shares Q1 2025 Financial Insights

Updated Category News Views 374

Financial Overview of United Parks & Resorts Inc. United Parks & Resorts Inc. (NYSE: PRKS), a prominent player in the theme park and entertainment sector, has recently shared its financial results for the first quarter of 2025. This report delves into the key metrics and operational insights that define the company’s performance in this period. Attendance and Revenue...

Continue Reading
Seongnam Pavilion Sets New Benchmark at CES 2025 with 41 Companies

Updated Category News Views 178

Seongnam Pavilion Makes Waves at CES 2025 At the latest CES 2025, Seongnam City showcased an impressive turnout at the world's leading consumer electronics exhibition. This year, Seongnam participated with a remarkable delegation of 41 companies, marking the largest participation ever. Focused on enhancing their global footprint, these small and medium-sized enterprises...

Continue Reading
Gaucho Holdings Seizes Opportunities Amid Argentina's Economic Revival

Updated Category News Views 179

Gaucho Holdings and the New Economic Landscape in Argentina Recently, Argentina has entered a new chapter of economic transformation. A shift in leadership, with Javier Milei becoming president, has sparked hopes for fiscal discipline, growth, and development. As the country embraces pro-market reforms, Gaucho Group Holdings, Inc. (NASDAQ: VINO) positions itself to...

Continue Reading